1. Shirai, T.: Significance of chemoprevention for prostate cancer development: Experimental in vivo approaches to chemoprevention. Pathol. Int., 58: 1-16, 2008.
2. Hikosaka, A., Ogawa, K., Sugiura, S., Asamoto, M., Takeshita, F., Sato, SY., Nakanishi, M., Kohri, K., Shirai, T.: Susceptibility of p27kip1 knockout mice to urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine may not simply be due to enhanced proliferation. Int J Cancer, 122: 1222-1228, 2008.
3. Nabae, K., Hayashi, SM., Kawabe, M., Ichihara, T., Hagiwara, A., Tamano, S., Tsushima, Y., Uchida, K., Koda, T., Nakamura, M., Ogawa, K., Shirai, T.: A 90-day oral toxicity study of purple corn color, a natural food colorant, in F344 rats. Fd Chem Toxicol, 46: 774-780, 2008.
4. Yamashita, S., Takahashi, S., McDonell, N., Watanabe, N., Niwa, T., Hosoya, K., Tsujino, Y., Shirai, T., Ushijima, T.: Methylation silencing of transforming growth Factor-β receptor type II in rat prostate cancers. Cancer Res., 68: 2112-2121, 2008.
5. Yamanaka, H., Yakabe, Y., Saito, K., Sekijima, M., Sato, H., Shirai, T.: High-accuracy prediction of carcinogenicity by global quantitative analysis of post-translational modifications in a 28-day in vivo rat study. Cancer Genomics Proteomics, 5: 105-116, 2008.
6. Seeni, A., Takahashi, S., Takeshita, K., Tang, M., Sugiura, S., Sato, S., Shirai, T.: Suppression of prostate cancer growth by resveratrol in the transgenic rat for adenocarcinoma of prostate (TRAP) model. Asian Pac J Cancer Prev, 9: 7-14, 2008.
7. Hokaiwado, N., Takeshita, F., Naiki-Ito, A., Asamoto, M., Ochiya, T., Shirai, T.: Glutathione S-transferase pi mediates proliferation of androgen-independent prostate cancer cells. Carcinogenesis, 29: 1134-1138, 2008.
8. Tanaka, Y., Sanchez, LV., Sugiyama, M., Sakamoto, T., Kurbanov, F., Tatematsu, K., Roman, S., Takahashi, S., Shirai, T., Panduro, A., Mizokami, M.: Characteristics of hepatitis B virus genotype G coinfected with genotype H in chimeric mice carrying human hepatocytes. Virology, 376: 408–415, 2008.
9. Mizoguchi, Y., Ogawa, K., Futakuchi, M., Takahashi, S., Hirose, M., Shirai, T.: Differences in expression patterns of cell cycle regulators after cessation of genotoxic and non-genotoxic carcinogen treatment in the rat forestomach. J Toxicol Pathol, 21: 77-87, 2008.
10. Hagiwara, H., Sato, H., Ohde, Y., Takano, Y., Seki, T., Ariga, T., Hokaiwado, N., Asamoto, M., Shirai, T., Nagashima, Y., Yano, T.: 5-Aza-2’-deoxycytidine suppresses human renal carcinoma cell growth in a xenograft model via up-regulation of the connexin 32 gene. Br J Pharmacol, 153: 1373-1381, 2008.
11. Nakagawa, M., Hara, M., Shibamoto, Y., Yano, M., Takahashi, S.: CT findings of bronchial glandular papilloma. J Thorac Imaging, 23: 210-212, 2008.
12. Nakagawa, M., Hara, M., Oshima, H., Shibamoto, Y., Sato, Y., Kondo, S., Suzuki, T., Takahashi, S.: Pleural bronchogenic cysts: Imaging findings. J Thorac Imaging, 23: 284-288, 2008.
13. Kawabe, M., Futakuchi, M., Tamano, S., Shirai, T., Hirose, M.: Modifying effects of chitin, chitosan and their related compounds on 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in a rat medium-term hepatocarcinogenesis model, and their post-initiation effects in a female rat 2-stage multi-organ carcinogenesis model. Fd Chem Toxicol, 46: 2758-2763, 2008.
14. Sato, S., Futakuchi, M., Ogawa, K., Asamoto, M., Nakao, K., Asai, K., Shirai, T.: Transforming growth factor beta derived from bone matrix promotes cell proliferation of prostate cancer and osteoclast activation-associated osteolysis in the bone microenvironment. Cancer Sci, 99: 316-323, 2008.
15. Wang, Z., Luque, RM., Kineman, RD., Ray, VH., Christov, KT., Lantvit, DD., Shirai, T., Hedayat, S., Unterman, TG., Bosland, MC., Prins, GS., Swanson, SM.: Disruption of growth hormone signaling retards prostate carcinogenesis in the probasin/TAg rat. Endocrinology, 149: 1366-1376, 2008.
16. Kawai, N., Futakuchi, M., Yoshida, T., Ito, A., Sato, S., Naiki, T., Honda, H., Shirai, T., Kohri, K.: Effect of heat therapy using magnetic nanoparticles conjugated with cationic liposomes on prostate tumor in bone. Prostate, 68: 784-792, 2008.
17. Toyama, T., Yamashita, H., Kondo, N., Okuda, K., Takahashi, S., Sasaki, H., Sugiura, H., Iwase, H., Fujii, Y.: Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers. BMC Cancer, 8: 309, 2008.
18. Uemura, H., Ishiguro, H., Ishiguro, Y., Hoshino, K., Takahashi, S., Kubota, Y.: Angiotensin II induces oxidative stress in prostate cancer. Mol Cancer Res, 6: 250-258, 2008.
19. Suzuki, S., Arnold, LL., Ohnishi, T., Cohen, SM.: Effects of inorganic arsenic on the rat and mouse urinary bladder. Toxicol Sci, 106: 350-363, 2008.
20. Nascimento, MG., Suzuki, S., Wei, M., Tiwari, A., Arnold, LL., Lu, X., Le, XC., Cohen, SM.: Cytotoxicity of combinations of arsenicals on rat urinary bladder urothelial cells in vitro. Toxicology, 249: 69-74, 2008.